Provided by Tiger Trade Technology Pte. Ltd.

AKESO

140.500
+1.3000.93%
Volume:9.85M
Turnover:1.37B
Market Cap:129.40B
PE:-100.13
High:141.800
Open:140.000
Low:137.300
Close:139.200
52wk High:179.000
52wk Low:60.600
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:0.75
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.403
ROE:-14.53%
ROA:-4.64%
PB:12.56
PE(LYR):-100.13
PS:37.20

Loading ...

Akeso, Inc.'s (HKG:9926) Intrinsic Value Is Potentially 74% Above Its Share Price

Simply Wall St.
·
Oct 28, 2025

Summit Therapeutics Raises $500 Million in Private Placement

Reuters
·
Oct 22, 2025

JiAYin International: Strongly Bullish on Akeso (09926) with a Buy Rating and Target Price of HKD 183

Stock News
·
Oct 21, 2025

Akeso's Ivonescimab Shows Strong Phase 3 Results in Lung Cancer Trial

MT Newswires Live
·
Oct 21, 2025

BUZZ-Summit falls after not disclosing overall survival benefit in lung cancer trial

Reuters
·
Oct 20, 2025

Akeso (09926): HARMONi-6 Study Results Comparing Ivosidenib Combined Chemotherapy with Tezolizumab Combined Chemotherapy for First-Line Treatment of Advanced sq-NSCLC Published in The Lancet & 2025 ESMO Conference

Stock News
·
Oct 20, 2025

Akeso, Inc. (Stock Code: 9926) Announces Positive HARMONi-6 Results Published in The Lancet and Presented at 2025 ESMO

Bulletin Express
·
Oct 20, 2025

Akeso Reports Significant Survival Benefit for Cadonilimab in First-Line Advanced Gastric Cancer

Reuters
·
Oct 19, 2025

Akeso Reports Ivonescimab Combo Significantly Improves PFS in Advanced Squamous NSCLC

Reuters
·
Oct 19, 2025

Hong Kong Stock Market Analysis | Various Manipulations Behind Many Strategies and Severe Volume Reduction Favours Consumer Giants

Stock News
·
Oct 16, 2025

Akeso Inc. Announces Landmark Phase III HARMONi-6 Trial Results of Ivonescimab for Advanced Squamous NSCLC, Published in The Lancet and Highlighted at ESMO 2025

Reuters
·
Oct 16, 2025

HK Stocks in Motion | Akeso (09926) Surges Over 8% Amid Upcoming Publication of HARMONi-6 Study Results in The Lancet and ESMO LBA

Stock News
·
Oct 16, 2025

Is a Second Wave of Rally Starting? High-Volatility Hong Kong Stock Connect Innovative Drug ETF (520880) Soars 3.6%! DualityBio-B, 3SBIO, and Akeso Surge Collectively

Deep News
·
Oct 16, 2025

Analysis of Stock Holdings in Hong Kong Connect | October 16

Stock News
·
Oct 16, 2025

Analysis of Hong Kong Stocks | Favorable Conditions Strengthen Exchange Rates, Market Blossoms, Pharmaceuticals Worthy of Exploitation

Stock News
·
Oct 15, 2025